Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis

Abstract Currently available rabies post‐exposure prophylaxis (PEP) for use in humans includes equine or human rabies immunoglobulins (RIG). The replacement of RIG with an equally or more potent and safer product is strongly encouraged due to the high costs and limited availability of existing RIG....

Popoln opis

Bibliografske podrobnosti

Principais autores:	Paola De Benedictis, Andrea Minola, Elena Rota Nodari, Roberta Aiello, Barbara Zecchin, Angela Salomoni, Mathilde Foglierini, Gloria Agatic, Fabrizia Vanzetta, Rachel Lavenir, Anthony Lepelletier, Emma Bentley, Robin Weiss, Giovanni Cattoli, Ilaria Capua, Federica Sallusto, Edward Wright, Antonio Lanzavecchia, Hervé Bourhy, Davide Corti
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer Nature 2016-03-01
Serija:	EMBO Molecular Medicine
Teme:	human monoclonal antibody lyssaviruses post‐exposure prophylaxis rabies
Online dostop:	https://doi.org/10.15252/emmm.201505986
Oznake:	Označite Brez oznak, prvi označite!